Domestic ViolenceDVHPDINCT02021838
Evaluation of the Office on Violence Against Women's Domestic Violence Homicide Prevention Demonstrative Initiative
An observational study of Domestic Violence, run by Yale University at 1 site in United States.
Trial summary
In collaboration with the National Institute of Justice (NIJ) and the Office for Violence Against Women (OVW) the Yale University team will evaluate the implementation process and impact of the U.S. Department of Justice's Domestic Violence Homicide Prevention Demonstration Initiative. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Domestic Violence
- What is being tested?
- Lethality Assessment Program and Domestic Violence High Risk Team
- How many people
- 666 participants
- Where
- 1 siteUnited States
- Study dates
- 1 Jan 2014to 31 Dec 2020
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: The study will include all domestic violence offenders and victims within the six communities.
The demonstration sites are:
California North Carolina Ohio Illinois Michigan Tennessee
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Evaluation of the Domestic Violence Homicide Prevention Initiative
In collaboration with the National Institute of Justice (NIJ) and the Office for Violence Against Women (OVW) the Yale University team will evaluate the implementation process and impact of the U.S. Department of Justice's Domestic Violence Homicide Prevention Demonstration Initiative. This evaluation seeks to draw critical findings and potential lessons from the combined experience of the sites including: 1) how the models work in different communities; 2) the barriers and facilitators to implementing the models; and 3) outcomes of the model delivery. The evaluation team will also disseminate the findings with the goal of informing replication.
Read the detailed description
Process Evaluation: The process evaluation will assess: 1) the training and technical assistance provided to sites; 2) the implementation of the models in the communities; and 3) characteristics of the service delivery systems.
Technical Assistance Providers will document the training and technical assistance (TTA) they provide to the sites.
Sites will be asked to identify key stakeholders to participate in interviews before the implementation begins and then two additional times during the demonstration phase. Key informant interviews will assess: recipient's perception of the training and technical assistance; model fidelity; model implementation (including model penetration, barriers and facilitators to implementation); and, perceptions of model impact. In addition to key informant interviews administrative data will be gathered to assess aspects of model implementation and systematic observations of law enforcement initiated screens will be conducted by a member of the evaluation team who will join patrol officers for "ride-alongs".
Impact Evaluation: The impact evaluation will assess changes in: 1) collaboration among service sectors; 2) supervision and sanctions for offenders; 3) recidivism and re-victimization; 4) victim reported feelings of safety; 5) utilization of resources; and 6) nature of safety planning.
System Collaboration will be assessed through a web-based survey completed at three time points by key stakeholders representing all potential partners in the community. Social network analysis will provide a visual depiction of how the network changes over time.
Victim Interviews will be conducted to determine the impact of involvement in the model program on their safety and wellbeing. Victims will be interviewed at three time points and will be asked about: prior and recent contact with law enforcement, domestic violence service providers or other providers; awareness of resources to address IPV; their safety and fear of their partner; coping strategies utilized; social support; financial resources; willingness to utilize criminal justice system and domestic violence service providers; both their and offenders behavior, beliefs and attitudes; self-reported mental health and substance abuse; their report of offenders substance abuse; and demographic information.
Administrative Data will be utilized to examine the breadth of the model implementation; the impact of the model programs on criminal justice processes; and whether there is a connection between the extent of post-risk assessment sanctions and services and the pattern of newly recorded incidents between the victim and offender. The evaluation will compare processing and outcomes across cases that are in many ways similar except that some cases were determined to be high risk and a risk assessment was completed and others where a risk assessment was not conducted. To facilitate these comparisons, the evaluation team will build a comprehensive database that will depict the "life-history" of each victim and offender dyad.
- Conditions
- Domestic Violence
- Being tested
- Lethality Assessment Program, Domestic Violence High Risk Team
- Keywords
- domestic violence homicide prevention
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Lethality Assessment ProgramOther
Also called LAP
Law enforcement officers conduct risk screen of domestic violence victims, if high risk victims are referred to domestic violence services.
Domestic Violence High Risk TeamOther
Also called HRT
Law enforcement officers conduct risk screen of domestic violence victims, if high risk victims are referred to domestic violence services and a team who monitors the clinical and criminal justice progress.
| Study group | Role | What they receive |
|---|---|---|
| California | Lethality Assessment Program Receives: Other: Lethality Assessment Program | |
| North Carolina | Lethality Assessment Program Receives: Other: Lethality Assessment Program | |
| Ohio | Domestic Violence High Risk Team Receives: Other: Domestic Violence High Risk Team | |
| Illinois | Lethality Assessment Program Receives: Other: Lethality Assessment Program | |
| Michigan | Lethality Assessment Program Receives: Other: Lethality Assessment Program | |
| Tennessee | Lethality Assessment Program Receives: Other: Lethality Assessment Program |
What is being measured
The primary outcome is the main question the study is designed to answer.
Decreased frequency of re-assault
Decrease in harassment, assault, injury, homicide/mortality
Measured: up to 3 years
Secondary outcomes (5)
Increased collaboration between network partners
Increased information sharing, case planning, coordinated response
Measured: up to 3 years
Increased awareness of and utilization of resources for victims
Increased awareness of and utilization of community resources
Measured: Up to 3 years
Increased safety planning
Increased safety planning at the time of police intervention
Measured: Up to 3 years
Increased victim reported safety
Victim reported changes in perceptions of safety
Measured: Up to 3 years
Increased sanctions for offender
Sanctions such as pre-trial containment, cases to trial, adjudications, containment post-adjudication
Measured: Up to 3 years
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted27 Dec 2013 (estimated)
- Study start1 Jan 2014
- Primary completion31 Dec 2020
- Study completion31 Dec 2020
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Domestic ViolenceStudies of the same condition, open and under way.
- More trials run by Yale UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 666 participants (actual)
Sponsor and investigators
- Lead sponsor
- Yale University
- Sponsor type
- University, hospital or other
- Collaborators
- Michigan State University
- Responsible party
- Sponsor
- Investigators
- Joy S Kaufman, PhD, Principal investigator, Yale UniversityChristopher Maxwell, PhD, Study director, Michigan State UniversityTami Sullivan, PhD, Study director, Yale University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT02021838
- Sponsor's protocol ID
- 1311013010
- Acronym
- DVHPDI
- Status last verified
- Mar 2021
- First submitted
- 12 Dec 2013
- Last updated
- 24 Mar 2021
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Yes: Data will be archived with the National Institute of Justice
Study at a glance
From the registry record, last updated by the sponsor on 24 Mar 2021. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Evaluation of the Domestic Violence Homicide Prevention Initiative
- ClinicalTrials.gov ID
- NCT02021838
- Acronym / sponsor ID
- DVHPDI / 1311013010
- Conditions
- Domestic Violence
- Keywords
- domestic violence homicide prevention
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 666 participants (actual)
- Lead sponsor
- Yale UniversityUniversity, hospital or other
- Collaborators
- Michigan State University
- Study start
- 1 Jan 2014 (actual)
- Primary completion
- 31 Dec 2020 (actual)
- Study completion
- 31 Dec 2020 (actual)
- First posted
- 27 Dec 2013 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
In collaboration with the National Institute of Justice (NIJ) and the Office for Violence Against Women (OVW) the Yale University team will evaluate the implementation process and impact of the U.S. Department of Justice's Domestic Violence Homicide Prevention Demonstration Initiative. This evaluation seeks to draw critical findings and potential lessons from the combined experience of the sites including: 1) how the models work in different communities; 2) the barriers and facilitators to implementing the models; and 3) outcomes of the model delivery. The evaluation team will also disseminate the findings with the goal of informing replication.
Detailed description
Process Evaluation: The process evaluation will assess: 1) the training and technical assistance provided to sites; 2) the implementation of the models in the communities; and 3) characteristics of the service delivery systems.
Technical Assistance Providers will document the training and technical assistance (TTA) they provide to the sites.
Sites will be asked to identify key stakeholders to participate in interviews before the implementation begins and then two additional times during the demonstration phase. Key informant interviews will assess: recipient's perception of the training and technical assistance; model fidelity; model implementation (including model penetration, barriers and facilitators to implementation); and, perceptions of model impact. In addition to key informant interviews administrative data will be gathered to assess aspects of model implementation and systematic observations of law enforcement initiated screens will be conducted by a member of the evaluation team who will join patrol officers for "ride-alongs".
Impact Evaluation: The impact evaluation will assess changes in: 1) collaboration among service sectors; 2) supervision and sanctions for offenders; 3) recidivism and re-victimization; 4) victim reported feelings of safety; 5) utilization of resources; and 6) nature of safety planning.
System Collaboration will be assessed through a web-based survey completed at three time points by key stakeholders representing all potential partners in the community. Social network analysis will provide a visual depiction of how the network changes over time.
Victim Interviews will be conducted to determine the impact of involvement in the model program on their safety and wellbeing. Victims will be interviewed at three time points and will be asked about: prior and recent contact with law enforcement, domestic violence service providers or other providers; awareness of resources to address IPV; their safety and fear of their partner; coping strategies utilized; social support; financial resources; willingness to utilize criminal justice system and domestic violence service providers; both their and offenders behavior, beliefs and attitudes; self-reported mental health and substance abuse; their report of offenders substance abuse; and demographic information.
Administrative Data will be utilized to examine the breadth of the model implementation; the impact of the model programs on criminal justice processes; and whether there is a connection between the extent of post-risk assessment sanctions and services and the pattern of newly recorded incidents between the victim and offender. The evaluation will compare processing and outcomes across cases that are in many ways similar except that some cases were determined to be high risk and a risk assessment was completed and others where a risk assessment was not conducted. To facilitate these comparisons, the evaluation team will build a comprehensive database that will depict the "life-history" of each victim and offender dyad.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Number of arms
- 6
| Arm | Type | Receives |
|---|---|---|
| California | – | Other: Lethality Assessment ProgramLethality Assessment Program |
| North Carolina | – | Other: Lethality Assessment ProgramLethality Assessment Program |
| Ohio | – | Other: Domestic Violence High Risk TeamDomestic Violence High Risk Team |
| Illinois | – | Other: Lethality Assessment ProgramLethality Assessment Program |
| Michigan | – | Other: Lethality Assessment ProgramLethality Assessment Program |
| Tennessee | – | Other: Lethality Assessment ProgramLethality Assessment Program |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- The study will include all domestic violence offenders and victims within the six communities.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Lethality Assessment ProgramAlso: LAPLaw enforcement officers conduct risk screen of domestic violence victims, if high risk victims are referred to domestic violence services. | Other | California, Illinois, Michigan, North Carolina, Tennessee |
| Domestic Violence High Risk TeamAlso: HRTLaw enforcement officers conduct risk screen of domestic violence victims, if high risk victims are referred to domestic violence services and a team who monitors the clinical and criminal justice progress. | Other | Ohio |
Primary outcome
Decreased frequency of re-assault
Time frame: up to 3 years
Decrease in harassment, assault, injury, homicide/mortality
5 secondary outcomes
Increased collaboration between network partners
Time frame: up to 3 years
Increased awareness of and utilization of resources for victims
Time frame: Up to 3 years
Increased safety planning
Time frame: Up to 3 years
Increased victim reported safety
Time frame: Up to 3 years
Increased sanctions for offender
Time frame: Up to 3 years
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 24 Mar 2021.
- Individual participant dataSharing planned: Yes. Data will be archived with the National Institute of Justice
Related trials for Domestic Violence
RecruitingObservational study
Self-Dehumanization and Hesitation to Report Domestic Violence
Domestic Violence
Active, not recruiting
Community Resiliency Collective Efficacy Intervention
Violence, Physical, Violence, Non-accidental
Enrolling by invitation
Evaluation of a Trauma-Informed Partner Violence Intervention Program
Domestic Violence, Post Traumatic Stress Disorder
Not yet recruiting
Metacognitive Interpersonal Therapy for Male Intimate Partner Violence Perpetrators With Personality Disorders
Intimate Partner Violence, Personality Disorders
RecruitingObservational study
Evaluation of the Impact on Mental and Physical Health of Caring for Women Who Are Victims of Sexual and Gender-based Violence, Using a Coordinated Multidisciplinary Approach in Women's Centres or Traditional Health Centres.
Domestic and/or Sexual Violence
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Joy S Kaufman, PhD principal investigator
Yale University
Christopher Maxwell, PhD study director
Michigan State University
Tami Sullivan, PhD study director
Yale University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Domestic Violence, run by Yale University at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 24 Mar 2021. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Decreased frequency of re-assault (time frame: up to 3 years). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Mar 2021.